2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$283.69-$1.50 (-0.53%)
Price as of Oct 22, 2026 7:58 PM EDT- $503.3BMarket Cap
- 28.27%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$283.69-$1.50 (-0.53%)
ABBV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $285.19 | ||
Change | -$4.28 (-1.48%) | ||
Open | $284.57 | ||
High | $285.76 | ||
Low | $278.01 | ||
Previous Close | $289.08 | ||
Volume | 4,394,523 | ||
30-Day Average Volume | 4,844,311 | ||
1-Week Change | 1.08% | ||
1-Month Change | 8.34% | ||
1-Year Change | 28.27% | ||
3-Year Change | 115.19% | ||
5-Year Change | 212.75% | ||
Fundamentals | |||
Shares Outstanding | 1.8B | ||
Total Assets | $135.1B | ||
Market Cap | $503.3B | ||
Enterprise Value | $567.5B | ||
Period: QTR TTM FY | |||
Revenue | $17.0B | ||
Net Income | $3.6B | ||
Free Cash Flow | $3.1B | ||
EBIT | $5.0B | ||
EBITDA | $6.6B | ||
Net Working Capital | -$8.0B | ||
EPS | $2.03 | ||
Enterprise Value/EBITDA | 85 | ||
Enterprise Value/Revenue | 33 | ||
P/B | -85 | ||
P/E | 140 | ||
PEG | 0 | ||
Price/Free Cash Flow | 162 | ||
Price/Operating Cash Flow | 146 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.43% | ||
Trailing Annual Dividend Yield | 2.43% | ||
Ex-Dividend Date | 10/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield